Teva to sell 79 drugs to gain approval for Allergan’s generic business
Teva Pharmaceutical Industries will sell the rights and assets related to 79 pharmaceutical products to settle the government’s anticompetitive claims surrounding its $40.5 billion purchase of Allergan’s generic drug business....To view the full article, register now.
Already a subscriber? Click here to view full article